AXIM BIOTECHNOLOGIES, INC. Recognition of Deferred Revenue
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Recognition of Deferred Revenue of $45.50 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Income Statement › Other Income
us-gaap:RecognitionOfDeferredRevenue · last filed 2024-08-19
- AXIM BIOTECHNOLOGIES, INC. recognition of deferred revenue for the quarter ending 2024-06-30 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. recognition of deferred revenue for the quarter ending 2024-03-31 was $45.50K.
- AXIM BIOTECHNOLOGIES, INC. recognition of deferred revenue for fiscal 2019 was $57.40K, a 61.73% decline from fiscal 2018.
- AXIM BIOTECHNOLOGIES, INC. recognition of deferred revenue for fiscal 2018 was $150.00K.
- AXIM BIOTECHNOLOGIES, INC. recognition of deferred revenue for fiscal 2017 was $0.00.
| Period end | Recognition of Deferred Revenue 3 month | Recognition of Deferred Revenue 6 month | Recognition of Deferred Revenue 12 month |
|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-08-19 | $45.50K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $45.50K 10-Q/A · filed 2024-05-22 | ||
| 2019-12-31 | $57.40K 10-K/A · filed 2020-05-20 | ||
| 2018-12-31 | $150.00K 10-K/A · filed 2020-05-20 | ||
| 2017-12-31 | $0.00 10-K · filed 2019-04-08 |